Trial Profile
Evaluation of the Usefulness of DurogesicD-TRANS for Pain Treatment in Lung Cancer Patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Jan 2013
Price :
$35
*
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- Sponsors Janssen
- 23 Jan 2013 Treatment table added.
- 09 Feb 2010 New trial record